Since Middle East respiratory syndrome (MERS) was described in September 2012, over 90 cases have been reported worldwide, 70 from Saudi Arabia. The incidence of infection with the causative agent, a betacoronavirus (MERS CoV) ([@R1]), has not been determined; however, the mortality rate among those who received clinical care is ≈65% ([@R2]). Although instances of human-to-human transmission have been documented between case-patients and others in close contact (including hospital patients sharing rooms, family members, and medical personnel), the sources of infection for most patients remain unknown. Because of sequence similarities between β-CoVs identified in bats and those of MERS CoV isolated from humans, a bat reservoir has been posited ([@R3]--[@R5]). Although neither detection of MERS CoV in bats nor contact of human MERS patients with bats have been reported, a role for bats in human infection cannot be excluded because contact can be indirect (mediated through another animal vector or fomites).

The Study
=========

In October 2012 and April 2013, three agencies collected samples from bats in regions where MERS cases had been identified ([Figure 1](#F1){ref-type="fig"}). The agencies are the Ministry of Health of Saudi Arabia, the Center for Infection and Immunity of Columbia University, and EcoHealth Alliance.

![Bat sampling sites and locations of home and workplace of index case-patient with Middle East respiratory syndrome, Bisha, Saudi Arabia.](13-1172-F1){#F1}

During the October investigation, the team interviewed the family of an index case-patient in Bisha and collected samples from bats \<12 km from his home, in an abandoned date palm orchard, and \<1 km from his place of employment, a hardware store that fronted a garden and date palm orchard. Although neither family members nor employees recalled seeing bats, the team observed roosting bats and guano in abandoned wells and ruins within 12 km of his home and insectivorous bats at dusk in the garden behind his store. Over 3 weeks, 96 bats representing 7 species (*Rhinopoma hardwickii*, *Rhinopoma microphyllum*, *Taphozous perforatus*, *Pipistrellus kuhlii*, *Eptesicus bottae*, *Eidolon helvum*, and *Rosettus aegyptiacus*) were captured in mist nets and harp traps, then released after visual speciation and collection of morphometric measurements; wing punch biopsy samples; blood; throat swab samples; and rectal swab samples or fecal pellets. Samples were collected into viral transport medium or lysis buffer.

During the 3-week April investigation, fecal samples were collected on tarps laid out at bat roosting sites in and around Bisha, Unaizah, and Riyadh. Representative animals at each roosting site were captured, identified morphologically, and released after wing punch biopsy samples were collected for speciation by DNA analysis. Samples were collected into cryovials.

All samples were stored in liquid nitrogen and conveyed to Riyadh for storage at −80°C before being transported to Columbia University in New York in dry nitrogen. The October 2012 shipment was inadvertently opened at customs in the United States and sat at room temperature for 48 hours before transfer to Columbia University; at arrival, all samples had thawed. The April 2013 samples arrived intact.

Total nucleic acid was extracted from samples by using the NucliSENS easyMAG system (bioMérieux, Durham, NC, USA) and subjected to 8 PCRs with primers and protocols designed to amplify regions within the helicase, RNA-dependent RNA polymerase (RdRp), and nucleocapsid or envelope proteins of CoVs ([@R6]--[@R9]). Products were sequenced and analyzed for similarity to GenBank database entries by using the BLASTn and BLASTx programs ([www.ncbi.nlm.nih.gov/blast/Blast.cgi](http://www.ncbi.nlm.nih.gov/blast/Blast.cgi)). Primer sequences are shown in [Table 1](#T1){ref-type="table"}. The identity of bat species yielding specific viral products was determined by amplifying and sequencing a fragment of the cytochrome B gene ([@R10]). All visual classifications of species were confirmed except for that of *T. perforatus* bats. There is no reference sequence for *T. perforatus* bats in GenBank. However, because the closest reference sequence was from *T. nudiventris* bats, at 84% identity we presume that the product represents bona fide *T. perforatus* bat cytochrome B gene sequence. Representative cytochrome B sequences have been uploaded to GenBank (accession nos. KF498635--KF498641).

###### PCRs and primers used in CoV detection\*

  PCRs (reference)                                 Primers, 5′→3′                                                          Nested fragment size, region (primer locations on the reference) genome)†   Type of CoV (no.)
  ------------------------------------------------ ----------------------------------------------------------------------- --------------------------------------------------------------------------- ----------------------
  Nested pan-CoV-I ([@R6])                         PLQ-F1, CGTTGGIACWAAYBTVCCWYTICARBTRGG                                  ≈400 nt, RdRp (18310--187450)                                               α-CoV (8), β-CoV (1)
  PLQ-R1, GGTCATKATAGCRTCAVMASWWGCNACATG                                                                                                                                                               
  PLQ-F2, GGCWCCWCCHGGNGARCAATT                                                                                                                                                                        
  PLQ-R2, GGWAWCCCCAYTGYTGWAYRTC                                                                                                                                                                       
  Nested pan-CoV-II ([@R7])                        WT-COV-F1, GGTTGGGAYTAYCCHAARTGTGA                                      ≈430 nt, RdRp (15260--15700)                                                α-CoV (5), β-CoV (2)
  WT-COV-R1, CCATCATCASWYRAATCATCATA                                                                                                                                                                   
  WT-COV-F2, GAYTAYCCHAARTGTGAYAGAGC                                                                                                                                                                   
  WT-COV-F3, GAYTAYCCHAARTGTGAUMGWGC                                                                                                                                                                   
  Hemi-nested RdRp-sequence assay ([@R9])          EMC-SeqRdRP-Rev, GCATWGCNCWGTCACACTTAGG                                 ≈230 nt, RdRp (15048--15290)                                                α-CoV (2), β-CoV (1)
  EMC-SeqRdRP-Fwd, TGCTATWAGTGCTAAGAATAGRGC                                                                                                                                                            
  EMC-SeqRdRP-Rnest, CACTTAGGRTARTCCCAWCCCA                                                                                                                                                            
  Hemi-nested N-sequence assay ([@R9])             EMC-SeqN-Fwd, CCTTCGGTACAGTGGAGCCA                                      ≈280 nt,N seq (29,549--29,860)                                              --
  EMC-SeqN-Rev, GATGGGGTTGCCAAACACAAAC                                                                                                                                                                 
  EMC-SeqN-Fnest, TGACCCAAAGAATCCCAACTAC                                                                                                                                                               
  Nested CII-pan-CoV-III                           NM-CoV-2F1, ACWGTTCARGGICCWCCIGG                                        ≈355 nt, helicase (17,060--17,410)                                          β-CoV (2)
  NM-CoV-2F2, GTTCARGGGCCWCCGGGNAC                                                                                                                                                                     
  NM-CoV-2R1, GGCAGCTGWGCWGGRTCICCNACRTA                                                                                                                                                               
  NM-CoV-2R2, AGCTGWGCWGGRTCGCCIACRTANAC                                                                                                                                                               
  Nested CII-MERS-RdRp                             NM-HCOV-F1, GTGCTAAGAATAGAGCTCGCACT NM-HCOV-F2, AGAGCTCGCACTGTTGCAGGC   ≈190 nt, RdRp (15068--15249)                                                β-CoV (1, MERS CoV)
  NM-HCOV-F2, AGAGCTCGCACTGTTGCAGGC                                                                                                                                                                    
  NM-HCOV-R1, ACCCATAAGATGCGGATTATCAAC                                                                                                                                                                 
  NM-HCOV-R2, TGCGGATTATCAACATCTTTGTAC                                                                                                                                                                 
  Hemi-nested CII-MERS N sequence                  NM-NSeq-F-1, ACTTCCTTCGGTACAGTGGAGC                                     ≈170 nt, N seq (29545--29713)                                               --
  NM-NSeq-R-1, GGCACTGTTCACTTGCAATC                                                                                                                                                                    
  NM-NSeq-R-2, GGAGGTTCAGACATTTGGTCT                                                                                                                                                                   
  upE and ORF1b real-time assays ([@R8])           upE-Fwd: GCAACGCGCGATTCAGTT                                             Upstream of E gene and ORF 1b                                               --
  upE-Prb: FAM-CTCTTCACATAATCGCCCCGAGCTCG-TAMRA                                                                                                                                                        
  upE-Rev: GCCTCTACACGGGACCCATA                                                                                                                                                                        
  ORF1b-Fwd: TTCGATGTTGAGGGTGCTCAT                                                                                                                                                                     
  ORF1b-Prb: FAM-CCCGTAATGCATGTGGCACCAATGT-TAMRA                                                                                                                                                       
  ORF1b-Rev: TCACACCAGTTGAAAATCCTAATTG                                                                                                                                                                 

\* CoV, coronavirus; MERS, Middle East respiratory syndrome; RdRp, RNA-dependent RNA polymerase; --, not applicable; ORF, open reading frame. †Primer locations are based on human β-CoV 2c EMC/2012, complete genome (GenBank accession no. JX869059).

[Table 1](#T1){ref-type="table"} indicates the CoV genera identified by using individual primer sets. As anticipated, pan-CoV assays detected α- and β-CoVs. One assay specific for MERS CoV ([@R9]) also detected α-CoVs. This finding reinforces the need for sequence confirmation of PCR products. [Table 2](#T2){ref-type="table"} indicates the CoV species identified with respect to location, sample type, and bat species. CoV sequences were amplified from rectal swab samples or fecal pellets and from roost feces but not from serum, throat swab samples, or urine. Alpha CoV sequences were amplified more frequently than β-CoV sequences (223 vs 4). Whereas α- and β-CoV sequences were amplified from CoVs from *T. perforatus*, *E. helvum,* and *R. hardwickii* bats, only alpha sequences were amplified from CoVs from *P. kuhlii* bat samples.

###### CoVs detected in bats, Saudi Arabia\*

  Bat family, genus, species   Location               No. Bats   No. samples tested (no. positive)   Total samples (n = 1,003)   Total positive samples (n = 227) (closely related CoVs)†                           
  ---------------------------- ---------------------- ---------- ----------------------------------- --------------------------- ---------------------------------------------------------- ----- ----------- ----- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *Taphozous perforatus*       Bisha ruins            29         29 (0)                              25 (2)                      8 (0)                                                      22    10 (1)      94    1 β-Cov (1 MERS novel CoV) and 2 α-CoVs (1 bovine respiratory CoV, 1 Kenya bat CoV BtKY86)
  Pteropodidae                                                                                                                                                                                                      
  *Eidolon helvum*             Bisha town center      25         25 (0)                              25 (5)                      13 (0)                                                     19    --          82    1 β-CoV (1 *Eidolon* bat CoV-HKU1) and  4 α-CoVs (4 Kenya bat CoV BtKY86)
  *Rousettus aegyptiacus*      Bisha town center      3          3 (0)                               3 (0)                       1 (0)                                                      2     --          9     --
  Rhinopomatidae                                                                                                                                                                                                    
  *Rhinopoma hardwickii*       Naqi and Old Naqi      36         36 (0)                              35 (0)                      4 (0)                                                      --    15 (0)      90    --
  *Rhinopoma microphyllum*     Old Naqi               1          1 (0)                               1 (0)                       --                                                         --    --          2     --
  Vespertilionidae                                                                                                                                                                                                  
  *Eptesicus bottae*           Bisha ruins            1          1 (0)                               1 (0)                       1 (0)                                                      --    32 (0)      35    *--*
  *Pipistrellus kuhlii*        Bisha ruins            1          1 (0)                               1 (0)                       --                                                         --    --          2     --
  April 2013                                                                                                                                                                                                        
  Rhinopomatidae                                                                                                                                                                                                    
  *Rhinopoma hardwickii*       Greater Bisha area     --         --                                  --                          --                                                         --    209 (93)    209   2 β-CoVs (2 canine respiratory CoVs) and 91α-CoVs (5 canine CoVs, 2 *Miniopterus* bat CoVs, 84 *Chaerephon* bat CoV)
  *Taphozous perforatus*       Bisha ruins            --         --                                  --                          --                                                         --    203 (0)     203   --
  Vespertilionidae                                                                                                                                                                                                  
  *Pipistrellus kuhlii*        Greater Unaizah area   9          9 (0)                               --                          --                                                         ---   263 (126)   277   126 α-CoVs (69 alphaCoV P.kuh-Spain, 3 canine CoVs, 37 bat CoV P.pyg/Germany, 1 human CoV NL63, 2 *Rousettus* bat CoV HKU10, 11 Porcine epidemic diarrhea virus, 2 *Cardioderma* bat CoVs, 1 *Hipposideros* bat CoV HKU10)
  Greater Riyadh area          5                      5 (0)      --                                  --                          --                                                         --    --          --    

\*CoV, coronavirus; MERS, Middle East respiratory syndrome; --, not applicable.  †Based on BLASTn ([www.ncbi.nlm.nih.gov/blast/Blast.cgi](www.ncbi.nlm.nih.gov/blast/Blast.cgi)).

CoV sequences were amplified from 220 of 732 roost feces samples and 7 of 91 rectal swab samples or fecal pellets. A product obtained by PCR amplification of nucleic acid from a fecal pellet of a *T. perforatus* bat captured in October 2012 in Bisha showed 100% nt identity to the human β-CoV 2c EMC/2012 cloned from the index case-patient in Bisha. A phylogenetic analysis of CoVs obtained in this study is shown in [Figure 2](#F2){ref-type="fig"}. CoV sequences have been uploaded in GenBank (accession nos. KF493884--KF493888).

![Phylogenetic tree showing genetic relatedness between coronaviruses identified in bat samples from Saudi Arabia (**boldface**), MERS coronaviruses, and other published coronavirus sequences available in GenBank. The maximum-likelihood tree of partial RNA-dependent RNA polymerase gene (nt position 15068--15249 of GenBank accession no. JX869059) was constructed by using the Tamura-Nei model with discrete gamma rate differences among sites as implemented in MEGA 5.2 ([www.megasoftware.net](www.megasoftware.net)). Each branch shows the GenBank accession number followed by a brief description of the sequence used. Scale bar indicates nucleotide substitutions per site. MERS, Middle East respiratory syndrome; CoV, coronavirus; SARS, severe acute respiratory syndrome; KSA, Kingdom of Saudi Arabia.](13-1172-F2){#F2}

Conclusions
===========

A wide range of CoV species are circulating among bats in Saudi Arabia. Although the prevalence of CoVs was high (≈28% of fecal samples), MERS CoV was found in only 1 bat. A 3.5% MERS CoV infection rate (n = 29; 95% CI 0--20%) in *T. perforatus* bats is low compared with that for severe acute respiratory syndrome--like CoV in rhinolophid bats in China (10%--12.5%) but consistent with CoV prevalence among bats in Mexico ([@R4]). Furthermore, the sensitivity for viral nucleic acid detection in samples collected in October 2012 was probably reduced because of failure in cold chain transport. Whereas 219 (32%) of 675 of fecal pellets collected in April revealed a CoV sequence by PCR, only 8 (5%) of 148 of rectal swab samples or fecal pellets collected in October were positive by the same assays. We were unable to recover additional sequences beyond the 190-nt RdRp fragment represented in [Figure 2](#F2){ref-type="fig"} but are confident in the fidelity of the finding. First, although RdRp is a conserved portion of the CoV genome, there is no precedent for 100% identity of a bat sequence with a human MERS CoV sequence. Second, when this work began we did not have cultured MERS CoV, human MERS samples, or MERS CoV cDNA in the laboratory at Columbia University where samples were removed directly from the tubes in which they were collected in the field for nucleic acid extraction, PCR, and sequence analysis. Third, the only MERS-positive signal was obtained in PCR analysis of the *T. perforatus* bat captured in Bisha near the home and workplace of the MERS index case-patient used to generate the human β-CoV 2c EMC/2012 sequence.

Bats are reservoirs of several viruses that can cause human disease, including rabies, Hendra, Nipah, Marburg, severe acute respiratory syndrome CoV, and probably Ebola viruses ([@R11]--[@R14]). Cross-species transmission from bats to humans can be direct, through contact with infected bats or their excreta, or facilitated by intermediate hosts ([@R15]). Bat CoVs are typically host specific; however, MERS-related CoVs have reportedly been found in many bat families, including Vespertillionidae, Molosidae, Nyteridae, and now Emballonuridae (sheath-tailed bats) in Africa, the Americas, Asia, and Europe. We sampled only a small sample of bats in Saudi Arabia. Nonetheless, given the rarity of MERS CoV sequences detected by our survey and the broad distribution of MERS cases throughout the Middle East, we speculate that there are probably other hosts. Future work should investigate additional bat and other wildlife species and domestic animals for CoV infection and potential linkage to human disease.
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